These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 29535628)
21. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2). Shen H; Lee FY; Gan J J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849 [TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of the Sesquiterpene Lactones Neoambrosin and Damsin from Ambrosia maritima Against Multidrug-Resistant Cancer Cells. Saeed M; Jacob S; Sandjo LP; Sugimoto Y; Khalid HE; Opatz T; Thines E; Efferth T Front Pharmacol; 2015; 6():267. PubMed ID: 26617519 [TBL] [Abstract][Full Text] [Related]
23. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901 [TBL] [Abstract][Full Text] [Related]
24. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183 [TBL] [Abstract][Full Text] [Related]
25. Human ATP-Binding Cassette transporters ABCB1 and ABCG2 confer resistance to CUDC-101, a multi-acting inhibitor of histone deacetylase, epidermal growth factor receptor and human epidermal growth factor receptor 2. Wu CP; Hsiao SH; Su CY; Luo SY; Li YQ; Huang YH; Hsieh CH; Huang CW Biochem Pharmacol; 2014 Dec; 92(4):567-76. PubMed ID: 25450670 [TBL] [Abstract][Full Text] [Related]
26. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway. Pick A; Wiese M ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538 [TBL] [Abstract][Full Text] [Related]
27. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Li H; Krstin S; Wink M Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981 [TBL] [Abstract][Full Text] [Related]
28. Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. Sachs J; Döhl K; Weber A; Bonus M; Ehlers F; Fleischer E; Klinger A; Gohlke H; Pietruszka J; Schmitt L; Teusch N Front Pharmacol; 2019; 10():400. PubMed ID: 31040786 [TBL] [Abstract][Full Text] [Related]
29. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
30. Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells. Tan KW; Sampson A; Osa-Andrews B; Iram SH Drug Metab Dispos; 2018 Dec; 46(12):1856-1866. PubMed ID: 30232176 [TBL] [Abstract][Full Text] [Related]
31. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010 [TBL] [Abstract][Full Text] [Related]
32. HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). Köhler SC; Wiese M J Med Chem; 2015 May; 58(9):3910-21. PubMed ID: 25855895 [TBL] [Abstract][Full Text] [Related]
33. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters. Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Teng QX; Chen ZS; Kong D; Yang DH Front Pharmacol; 2018; 9():1236. PubMed ID: 30425643 [TBL] [Abstract][Full Text] [Related]
34. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance. Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics of Scopoletin in Tumor Cells. Seo EJ; Saeed M; Law BY; Wu AG; Kadioglu O; Greten HJ; Efferth T Molecules; 2016 Apr; 21(4):496. PubMed ID: 27092478 [TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells. Saeed ME; Abdelgadir H; Sugimoto Y; Khalid HE; Efferth T J Ethnopharmacol; 2015 Nov; 174():644-58. PubMed ID: 26165828 [TBL] [Abstract][Full Text] [Related]
37. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547 [TBL] [Abstract][Full Text] [Related]
38. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106 [TBL] [Abstract][Full Text] [Related]
39. Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2. Silbermann K; Shah CP; Sahu NU; Juvale K; Stefan SM; Kharkar PS; Wiese M Eur J Med Chem; 2019 Feb; 164():193-213. PubMed ID: 30594677 [TBL] [Abstract][Full Text] [Related]
40. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2. Shukla S; Robey RW; Bates SE; Ambudkar SV Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]